{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T17:08:53Z","timestamp":1788196133376,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T00:00:00Z","timestamp":1772582400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","award":["5\/13\/2\/TF\/NHL\/2023\/NCD-III"],"award-info":[{"award-number":["5\/13\/2\/TF\/NHL\/2023\/NCD-III"]}],"id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Indian J Pediatr"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1007\/s12098-026-06035-w","type":"journal-article","created":{"date-parts":[[2026,3,4]],"date-time":"2026-03-04T02:57:48Z","timestamp":1772593068000},"page":"491-497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Assessing the Impact of Rituximab on Treatment Outcomes in Pediatric Advanced Mature B-Non Hodgkin Lymphoma"],"prefix":"10.1007","volume":"93","author":[{"given":"Ekta","family":"Rahul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Sasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuvadeep","family":"Ganguly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivek","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepam","family":"Pushpam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atul","family":"Batra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saumyaranjan","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehar Chand","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9367-4407","authenticated-orcid":false,"given":"Sameer","family":"Bakhshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,3,4]]},"reference":[{"key":"6035_CR1","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(17)30186-9","volume":"18","author":"E Steliarova-Foucher","year":"2017","unstructured":"Steliarova-Foucher E, Colombet M, Ries LAG, et al; IICC-3 Contributors. International incidence of childhood cancer, 2001\u201310: a population-based registry study. Lancet Oncol. 2017;18:719\u201331.","journal-title":"Lancet Oncol"},{"key":"6035_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1182\/asheducation-2016.1.589","volume":"2016","author":"JT Sandlund","year":"2016","unstructured":"Sandlund JT, Martin MG. Non-Hodgkin lymphoma across the pediatric and adolescent and young adult age spectrum. Hematol Am Soc Hematol Educ Program. 2016;2016:589\u201397.","journal-title":"Hematol Am Soc Hematol Educ Program"},{"key":"6035_CR3","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1007\/s12098-017-2563-2","volume":"85","author":"A Patel","year":"2018","unstructured":"Patel A, Sharma MC, Bakhshi S. Demographic challenges of pediatric NHL: a report on 280 patients. Indian J Pediatr. 2018;85:697\u20138.","journal-title":"Indian J Pediatr"},{"key":"6035_CR4","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1056\/NEJMoa1915315","volume":"382","author":"V Minard-Colin","year":"2020","unstructured":"Minard-Colin V, Aup\u00e9rin A, Pillon M, et al; European Intergroup for Childhood Non-Hodgkin Lymphoma; Children\u2019s Oncology Group. Rituximab for high-risk, mature B-cell non-Hodgkin\u2019s lymphoma in children. N Engl J Med. 2020;382:2207\u201319.","journal-title":"N Engl J Med"},{"key":"6035_CR5","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1016\/j.clnu.2022.05.010","volume":"41","author":"S Ganguly","year":"2022","unstructured":"Ganguly S, Srivastava R, Agarwala S, et al. Prevalence of micronutrient deficiency and its impact on the outcome of childhood cancer: a prospective cohort study. Clin Nutr. 2022;41:1501\u201311.","journal-title":"Clin Nutr"},{"key":"6035_CR6","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1080\/08880018.2021.2002485","volume":"39","author":"EA Rahiman","year":"2022","unstructured":"Rahiman EA, Bakhshi S, Deepam Pushpam, et al. Outcome and prognostic factors in childhood B non-Hodgkin lymphoma from India: report by the Indian Pediatric Oncology Group (InPOG-NHL-16-01 study). Pediatr Hematol Oncol. 2022;39:391\u2013405.","journal-title":"Pediatr Hematol Oncol"},{"key":"6035_CR7","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1111\/bjh.14030","volume":"173","author":"TG Gross","year":"2016","unstructured":"Gross TG, Biondi A. Paediatric non-Hodgkin lymphoma in low and middle income countries. Br J Haematol. 2016;173:651\u20134.","journal-title":"Br J Haematol"},{"key":"6035_CR8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/S1470-2045(11)70235-2","volume":"12","author":"M Pfreundschuh","year":"2011","unstructured":"Pfreundschuh M, Kuhnt E, Tr\u00fcmper L, et al; MabThera International Trial (MInT) Group. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. Lancet Oncol. 2011;12:1013\u201322.","journal-title":"Lancet Oncol"},{"key":"6035_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1002\/pbc.22905","volume":"56","author":"ML Moleti","year":"2011","unstructured":"Moleti ML, Al-Hadad SA, Al-Jadiry MF, et al. Treatment of children with B-cell non-Hodgkin lymphoma in a low-income country. Pediatr Blood Cancer. 2011;56:560\u20137.","journal-title":"Pediatr Blood Cancer"},{"key":"6035_CR10","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.arcped.2005.04.050","volume":"12","author":"M Harif","year":"2005","unstructured":"Harif M, Barsaoui S, Benchekroun S, et al. [Treatment of childhood cancer in Africa. Preliminary results of the French-African Paediatric Oncology Group]. Arch Pediatr. 2005;12:851\u20133.","journal-title":"Arch Pediatr"},{"key":"6035_CR11","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood.V97.12.3699","volume":"97","author":"K Seidemann","year":"2001","unstructured":"Seidemann K, Tiemann M, Schrappe M, et al. Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-M\u00fcnster Group Trial NHL-BFM 90. Blood. 2001;97:3699\u2013706.","journal-title":"Blood"},{"key":"6035_CR12","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/S1470-2045(22)00688-X","volume":"24","author":"KP Bhatia","year":"2023","unstructured":"Bhatia KP, Ganguly S, Sasi A, et al. Sex disparity in childhood cancer in India: a multi-centre, individual patient data analysis. Lancet Oncol. 2023;24:54\u201363.","journal-title":"Lancet Oncol"},{"key":"6035_CR13","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1007\/s12098-023-05010-z","volume":"91","author":"KP Bhatia","year":"2024","unstructured":"Bhatia KP, Ganguly S, Sasi A, et al. Sex bias in treatment abandonment of childhood cancer in India. Indian Indian J Pediatr. 2024;91:1119\u201321.","journal-title":"Indian Indian J Pediatr"},{"key":"6035_CR14","doi-asserted-by":"publisher","first-page":"e27620","DOI":"10.1002\/pbc.27620","volume":"66","author":"LA Williams","year":"2019","unstructured":"Williams LA, Richardson M, Marcotte EL, Poynter JN, Spector LG. Sex ratio among childhood cancers by single year of age. Pediatr Blood Cancer. 2019;66:e27620.","journal-title":"Pediatr Blood Cancer"},{"key":"6035_CR15","doi-asserted-by":"publisher","first-page":"E97","DOI":"10.1002\/pbc.24552","volume":"60","author":"B Biswas","year":"2013","unstructured":"Biswas B, Agarwala S, Rastogi S, et al. High burden of metastases and poor outcome in pelvic PNET. Pediatr Blood Cancer. 2013;60:E97\u20139.","journal-title":"Pediatr Blood Cancer"},{"key":"6035_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1080\/08880018.2023.2296949","volume":"41","author":"A Sasi","year":"2024","unstructured":"Sasi A, Chitikela S, Ganguly S, et al. Treatment outcomes in patients with Ewing sarcoma of the spine in a resource-challenged setting: 17-year experience from a single center in India. Pediatr Hematol Oncol. 2024;41:211\u201323.","journal-title":"Pediatr Hematol Oncol"},{"key":"6035_CR17","doi-asserted-by":"publisher","first-page":"e291","DOI":"10.1016\/j.clml.2019.01.008","volume":"19","author":"A Patel","year":"2019","unstructured":"Patel A, Tiwari A, Biswas B, Chand Sharma M, Vishnubhatla S, Bakhshi S. Clinical predictors and prognostic model for pediatric lymphoblastic lymphoma treated with uniform BFM90 protocol: a single-center experience of 65 patients from Asia. Clin Lymphoma Myeloma Leuk. 2019;19:e291\u20138.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"6035_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.4103\/ijmpo.ijmpo_42_16","volume":"39","author":"V Radhakrishnan","year":"2018","unstructured":"Radhakrishnan V, Shoufeej PM, Totadri S, Ganesan P, Ganesan T, Sagar T. Pediatric nonblastic non-Hodgkin\u2019s lymphoma: a perspective from India. Indian J Med Paediatr Oncol. 2018;39:13\u20137.","journal-title":"Indian J Med Paediatr Oncol"},{"key":"6035_CR19","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.phoj.2024.11.104","volume":"10","author":"N Roy Moulik","year":"2025","unstructured":"Roy Moulik N, Bakhshi S, Banavali S, et al. Pediatric mature B-cell non-Hodgkin lymphoma in India: a retrospective multicenter pooled analysis of treatment approaches and outcomes. Pediatr Hematol Oncol J. 2025;10:33\u201340.","journal-title":"Pediatr Hematol Oncol J"},{"key":"6035_CR20","first-page":"1","volume":"5","author":"GC Bouda","year":"2019","unstructured":"Bouda GC, Traor\u00e9 F, Couitchere L, et al. Advanced Burkitt lymphoma in Sub-Saharan Africa pediatric units: results of the third prospective multicenter study of the Groupe Franco-Africain d\u2019Oncologie P\u00e9diatrique. J Glob Oncol. 2019;5:1\u20139.","journal-title":"J Glob Oncol"},{"key":"6035_CR21","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1080\/10245332.2018.1510087","volume":"24","author":"F Gaytan-Morales","year":"2019","unstructured":"Gaytan-Morales F, Alejo-Gonzalez F, Reyes-Lopez A, et al; Mexican Association of Pediatric Oncology and Hematology (AMOHP). Pediatric mature B-cell NHL, early referral and supportive care problems in a developing country. Hematology. 2019;24:79\u201383.","journal-title":"Hematology"},{"key":"6035_CR22","doi-asserted-by":"publisher","first-page":"e2018020","DOI":"10.4084\/mjhid.2018.020","volume":"10","author":"P Angelini","year":"2018","unstructured":"Angelini P, Rodriguez L, Zolaly M, et al. Outcome and toxicity patterns in children and adolescents with non-Hodgkin lymphoma: a single institution experience. Mediterr J Hematol Infect Dis. 2018;10:e2018020.","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"6035_CR23","doi-asserted-by":"publisher","first-page":"e28682","DOI":"10.1002\/pbc.28682","volume":"67","author":"S Srinivasan","year":"2020","unstructured":"Srinivasan S, Roy Moulik N, Kc A, et al. Increased toxicities in children with Burkitt lymphoma treated with rituximab: experience from a tertiary cancer center in India. Pediatr Blood Cancer. 2020;67:e28682.","journal-title":"Pediatr Blood Cancer"},{"key":"6035_CR24","doi-asserted-by":"publisher","first-page":"e30694","DOI":"10.1002\/pbc.30694","volume":"70","author":"V Radhakrishnan","year":"2023","unstructured":"Radhakrishnan V, Kritthivasan V, Kothandan BT, Srinivasan P, Das G, Ramamurthy J. Reducing chemotherapy dose intensity by 25% and adding rituximab improves survival in pediatric mature B-cell non-Hodgkin lymphoma in LMIC setting. Pediatr Blood Cancer. 2023;70:e30694.","journal-title":"Pediatr Blood Cancer"},{"key":"6035_CR25","doi-asserted-by":"publisher","first-page":"2994","DOI":"10.1038\/s41375-021-01256-8","volume":"35","author":"S Goldman","year":"2021","unstructured":"Goldman S, Barth M, Shiramizu B, et al. A dose substitution of anthracycline intensity with dose-dense rituximab in children and adolescents with good-risk mature B-cell lymphoma. Leukemia. 2021;35:2994\u20137.","journal-title":"Leukemia"},{"key":"6035_CR26","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1111\/bjh.17979","volume":"196","author":"ML Moleti","year":"2022","unstructured":"Moleti ML, Testi AM, Fo\u00e0 R. Childhood aggressive B-cell non-Hodgkin lymphoma in low-middle-income countries. Br J Haematol. 2022;196:849\u201363.","journal-title":"Br J Haematol"},{"key":"6035_CR27","doi-asserted-by":"publisher","first-page":"e966","DOI":"10.1016\/S2352-3026(23)00279-X","volume":"10","author":"MED Chamuleau","year":"2025","unstructured":"Chamuleau MED, Stenner F, Chitu DA, et al. R-CODOX-M\/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON\/SAKK): final results of a multicentre, phase 3, open-label, randomised trial. Lancet Haematol. 2025;10:e966\u201375.","journal-title":"Lancet Haematol"},{"key":"6035_CR28","doi-asserted-by":"publisher","first-page":"e142","DOI":"10.1097\/FTD.0000000000001353","volume":"47","author":"M Larrosa-Gar\u00edca","year":"2025","unstructured":"Larrosa-Gar\u00edca M, Agraz Pamplona I, Sanz Mart\u00ednez MT, et al. Pharmacokinetic characterization of rituximab in patients with glomerular diseases. Ther Drug Monit. 2025;47:e142\u20139.","journal-title":"Ther Drug Monit"},{"key":"6035_CR29","unstructured":"National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India. Tender Document: 83cfb8c85fc0ceeae3ca5063d1c2c763. New Delhi: NPPA; 2025 Apr 01. https:\/\/nppa.gov.in\/uploads\/tender\/83cfb8c85fc0ceeae3ca5063d1c2c763.pdf. Accessed Feb 5, 2026."}],"container-title":["Indian Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-026-06035-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12098-026-06035-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12098-026-06035-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T06:59:40Z","timestamp":1777359580000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12098-026-06035-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,4]]},"references-count":29,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["6035"],"URL":"https:\/\/doi.org\/10.1007\/s12098-026-06035-w","relation":{},"ISSN":["0019-5456","0973-7693"],"issn-type":[{"value":"0019-5456","type":"print"},{"value":"0973-7693","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,4]]},"assertion":[{"value":"10 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}